Model Oncology, LLC has announced a new private offering to raise up to $17.5 million, according to a filing made on October 19, 2026. The company has already sold $10.9 million of this offering, leaving $6.585 million available for future sales. This move signifies the company's efforts to secure funding for operational needs, including compensation for its executive team.
The company, incorporated in Delaware, operates out of Nashville, Tennessee. Model Oncology, LLC is categorized under the 'Other Health Care' industry group. The filing indicates that the company has a revenue range it has chosen to decline to disclose, which is common for private entities.
According to the filing, the offering is structured under Rule 506(b), which provides a safe harbor for private offerings. The filing also noted that the company has accepted a minimum investment of $100,000 from accredited investors. A total of 30 investors have already participated in this offering.
The proceeds from this offering are intended for working capital, which may include normal compensation to executive officers. This reflects a strategic approach to ensure that the company maintains its operational capabilities while also compensating its leadership adequately.
The filing does not specify what steps will follow this offering or if there will be additional filings related to it. However, the successful sale of over $10 million suggests a level of confidence from investors in Model Oncology's future prospects.